Clinical Trials Logo
NCT number NCT03354429
Study type Interventional
Source AstraZeneca
Contact AstraZeneca Clinical Study Information Center
Phone 1-877-240-9479
Email information.center@astrazeneca.com
Status Not yet recruiting
Phase Phase 3
Start date January 31, 2018
Completion date December 16, 2019

Clinical Trial Summary

Study to investigate if the study drug ticagrelor and ASA is more effective than Placebo (inactive tablet) and ASA in preventing new stroke events.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms